CXCR4 expression functionally discriminates centroblasts versus centrocytes within human germinal center B cells.

Area of Science:

• Immunology
• Cell Biology
• Hematology

Background:

• Germinal centers are dynamic structures crucial for B cell differentiation.
• Centroblasts and centrocytes are key B cell subsets and normal counterparts for lymphomas.
• CD77 is an unreliable marker for distinguishing human centroblasts from centrocytes.

Purpose of the Study:

• To identify a reliable marker for separating human centroblasts from centrocytes.
• To characterize the phenotypic and functional differences between these B cell subpopulations.
• To provide purified normal counterparts for studying B cell malignancies.

Main Methods:

• Separation of B cell subpopulations based on chemokine receptor CXCR4 expression.
• Phenotypic and functional characterization of CXCR4(+) centroblasts and CXCR4(-) centrocytes.
• Microarray analysis to identify differentially expressed genes.
• Gene set enrichment analysis to compare B cell signatures with lymphoma data.

Main Results:

• CXCR4 expression reliably distinguishes human centroblasts from centrocytes.
• CXCR4(+) and CXCR4(-) B cells exhibit distinct proliferation, transcription factor expression, Ig production, and somatic hypermutation regulation.
• Microarray analysis revealed significant gene expression differences, including relevant genes.
• Centroblastic gene expression signature is enriched in Burkitt's lymphomas.

Conclusions:

• CXCR4 is a definitive marker for separating human centroblasts and centrocytes.
• This separation enables the purification of normal B cell counterparts for malignancy research.
• Findings provide insights into B cell differentiation and lymphoma pathogenesis.